Finoriq research workspace
Solventum Corp (SOLV) SEC Filings & Filing Highlights
Solventum Corporation, a healthcare company, develops, manufactures, and commercializes a. Review SOLV SEC filings, filing highlights, and disclosure activity on Finoriq.
Company Snapshot
Solventum Corporation, a healthcare company, develops, manufactures, and commercializes a portfolio of solutions to address critical customer and patient needs in the United States and internationally. It operates through three segments: Medsurg, Dental Solutions, and Health Information Systems. The Medsurg segment offers solutions, such as negative pressure wound therapy, advanced wound dressings, advanced skin care, synthetic tissue matrices, I.V. site management, sterilization assurance, temperature management, surgical supplies, medical tapes and wraps, stethoscopes, medical electrodes, and medical technologies for original equipment manufacturers. The Dental Solutions segment provides dental and orthodontic products, including brackets, aligners, restorative cements, and bonding agents to span the life of the tooth, and products for preventative dental care, direct and indirect restoration, and orthodontic needs. The Health Information Systems segment offers healthcare systems with software solutions comprising computer-assisted physician documentation, direct-to-bill and coding automation, classification methodologies, speech recognition, and data visualization platforms. The company sells its products and services through direct-to-consumer, distribution, key account management, inside sales, and e-commerce. Solventum Corporation was incorporated in 2023 and is headquartered in Eagan, Minnesota.
- Company
- Solventum Corp (SOLV)
- Ticker
- SOLV
- Market Cap
- $13.8B
- Latest Price
- $79.42
- Industry
- Medical Devices
Solventum Corp (SOLV) Recent SEC Filing Highlights
Recent SEC filings, filing events, and disclosure highlights indexed for Solventum Corp (SOLV).
| Event | Form | Date |
|---|---|---|
| Solventum Corp: Corporate updateOn May 10, 2024, Plaintiff Eric Gilbert (the “Plaintiff”), on behalf of a putative class of stockholders of Solventum Corporation (the “Com... | 8-K8.01 | 2026-06-05 |
| On May 21, 2026, the Talent Committee (the “Committee”) of the Board of Directors of Solventum...On May 21, 2026, the Talent Committee (the “Committee”) of the Board of Directors of Solventum Corporation (the “Company”) adopted and appr... | 8-K5.02 | 2026-05-27 |
| Broker Non-VotesSolventum Corporation (“Solventum”) held its annual meeting of shareholders on May 15, 2026. Set forth below are the final voting results f... | 8-K5.07 | 2026-05-20 |
| On May 5, 2026, Solventum issued a press release reporting first-quarter 2026 financial resultsOn May 5, 2026, Solventum issued a press release reporting first-quarter 2026 financial results (attached hereunder as Exhibit 99.1 and inc... | 8-K2.02 | 2026-05-05 |
| (b) On March 20, 2026, Mary Wilcox informed Solventum Corporation (the “Company”) of her intent...(b) On March 20, 2026, Mary Wilcox informed Solventum Corporation (the “Company”) of her intent to retire and resign from her position as C... | 8-K5.02 | 2026-03-24 |
Live data loads in the app
This static page shell gives search engines reliable page context. Current tables, filings, charts, and market data continue to load from Finoriq APIs after the application starts.